These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 23603557)
1. Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Nikiforuk A; Popik P Behav Brain Res; 2013 Jul; 248():136-40. PubMed ID: 23603557 [TBL] [Abstract][Full Text] [Related]
2. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Hołuj M; Popik P; Nikiforuk A Behav Pharmacol; 2015 Dec; 26(8 Spec No):766-75. PubMed ID: 25769091 [TBL] [Abstract][Full Text] [Related]
3. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone. Horisawa T; Nishikawa H; Toma S; Ikeda A; Horiguchi M; Ono M; Ishiyama T; Taiji M Behav Brain Res; 2013 May; 244():66-9. PubMed ID: 23376699 [TBL] [Abstract][Full Text] [Related]
4. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. Nikiforuk A; Kos T; Fijał K; Hołuj M; Rafa D; Popik P PLoS One; 2013; 8(6):e66695. PubMed ID: 23776692 [TBL] [Abstract][Full Text] [Related]
5. Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Nikiforuk A Behav Brain Res; 2012 Jan; 226(1):118-23. PubMed ID: 21925545 [TBL] [Abstract][Full Text] [Related]
7. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Nikiforuk A; Popik P Psychoneuroendocrinology; 2011 Jan; 36(1):28-39. PubMed ID: 20580164 [TBL] [Abstract][Full Text] [Related]
8. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats. Nikiforuk A; Fijał K; Potasiewicz A; Popik P; Kos T J Psychopharmacol; 2013 May; 27(5):469-76. PubMed ID: 23479455 [TBL] [Abstract][Full Text] [Related]
10. Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Perez-García GS; Meneses A Behav Brain Res; 2005 Aug; 163(1):136-40. PubMed ID: 15936093 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine. Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348 [TBL] [Abstract][Full Text] [Related]
12. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. Horiguchi M; Huang M; Meltzer HY J Pharmacol Exp Ther; 2011 Aug; 338(2):605-14. PubMed ID: 21558435 [TBL] [Abstract][Full Text] [Related]
13. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Nikiforuk A; Popik P Psychopharmacology (Berl); 2012 Mar; 220(1):65-74. PubMed ID: 21918808 [TBL] [Abstract][Full Text] [Related]
14. Effect of a 5-HT7 Receptor Antagonist on Reversal Learning in the Rat Attentional Set-Shifting Test. Hrnjadovic A; Friedmann J; Barhebreus S; Allen PJ; Kocsis B ACS Chem Neurosci; 2021 Jan; 12(1):42-48. PubMed ID: 33337152 [TBL] [Abstract][Full Text] [Related]
15. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Nikiforuk A; Hołuj M; Kos T; Popik P Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431 [TBL] [Abstract][Full Text] [Related]
16. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. Nikiforuk A; Gołembiowska K; Popik P Eur Neuropsychopharmacol; 2010 Jan; 20(1):37-48. PubMed ID: 19729284 [TBL] [Abstract][Full Text] [Related]
17. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185 [TBL] [Abstract][Full Text] [Related]
18. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality. Möller HJ Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970 [TBL] [Abstract][Full Text] [Related]
19. Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Abbas AI; Hedlund PB; Huang XP; Tran TB; Meltzer HY; Roth BL Psychopharmacology (Berl); 2009 Jul; 205(1):119-28. PubMed ID: 19337725 [TBL] [Abstract][Full Text] [Related]
20. Amisulpride alleviates chronic mild stress-induced cognitive deficits: Role of prefrontal cortex microglia and Wnt/β-catenin pathway. Mohamed AM; Habib MZ; Ebeid MA; Abdelraouf SM; El Faramawy Y; Aboul-Fotouh S; Magdy Y Eur J Pharmacol; 2020 Oct; 885():173411. PubMed ID: 32800810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]